Continuing Education (CE)
Continuing Education (CE)
Bayer has sponsored a variety of continuing education (CE) programs, which were developed to improve awareness and understanding of oncologic conditions.
All accredited CE/CME programs listed below were created independently by third-party providers and follow the standards set forth in the ACCME Standards for Commercial Support/Integrity and Independence in Accredited Continuing Education, or other similar accrediting organizations. Responsibility and control over selection, content, faculty, educational materials, and venue for the educational programs belong solely to the providers and/or accreditors. Bayer does not provide any guidance regarding the content or faculty for any programs receiving funding.
The list below is limited to CE programs supported by Bayer.
Last updated "April 2026".
Advancing Care for mCRPC With Life-Prolonging Therapies: Existing and Emerging Roles for Radiopharmaceuticals
PVI, PeerView Institute for Medical Education, Inc.
1.0 (AMA)
Intended Audience: Urologists, Medical Oncologists, and other Clinicians Involved in the Management of Patients with mCRPC
Updates to Cancer Survivorship: Optimizing Care and Outcomes
Harvard Medical School
20.5 (AMA)
Intended Audience: Primary Care Physicians, Physician Assistants, Nurses, Nurse Practitioners, Specialty Physicians, Psychologists, and Social Workers
Follow Us
